Unplanned delays among patients receiving FOLFOX chemotherapy for colorectal cancer.

被引：0
|
作者：
Kogan, Lawrence
Jankowski, Mika
O'Bryant, Cindy L.
Davis, Sarah Lindsey
Brooks, Gabriel A.
机构：
[1] Geisel Sch Med, Hanover, NH USA
[2] Univ Colorado, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA
[3] Univ Colorado, Sch Pharm, Aurora, CO USA
[4] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA
[5] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e15637
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15637
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Amifostine pretreatment for patients with advanced colorectal cancer receiving folfox chemotherapy
    Arena, F.
    Kurzyna-Solinas, A.
    Stark, R. F.
    Ohri, A.
    Schiffer, C.
    Sulzbach, H.
    Jemison, D.
    Dolat, J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Treatment delays during FOLFOX chemotherapy in patients with colorectal cancer: a multicenter retrospective analysis
    Kogan, Lawrence G.
    Davis, S. Lindsey
    Brooks, Gabriel A.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2019, 10 (05) : 841 - 846
  • [3] Obesity does not predict for unplanned dose reductions in patients receiving adjuvant chemotherapy for breast cancer.
    Jenkins, P
    Benstead, K
    Counsell, R
    Owen, R
    Elyan, S
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S206 - S207
  • [4] Chemotherapy-induced neutropenia with FOLFOX in the adjuvant treatment of colorectal cancer.
    Gotfrit, Joanna
    Marginean, Horia
    Maroun, Jean Alfred
    Trincao-Batra, Sara
    Asmis, Timothy R.
    Vickers, Michael M.
    Goodwin, Rachel Anne
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [5] Therapy monitoring with FDG PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Strauss, L
    Rudi, J
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 22P - 23P
  • [6] An administrative stage inference algorithm for use in patients receiving chemotherapy for colorectal cancer.
    Brooks, Gabriel A.
    Landrum, Mary Beth
    Keating, Nancy Lynn
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] UTILIZATION OF BEVACIZUMAB AMONG MEDICARE PATIENTS WITH COLORECTAL CANCER RECEIVING CHEMOTHERAPY
    Fu, A. Z.
    Tsai, H. T.
    Potosky, A. L.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A151 - A151
  • [8] Therapy monitoring with FDG-PET in patients with metastatic colorectal cancer receiving FOLFOX chemotherapy.
    Dimitrakopoulou-Strauss, A
    Rudi, J
    Strauss, LG
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 113P - 113P
  • [9] Dynamic impact of inflammation-based in colorectal cancer patients receiving FOLFOX-based chemotherapy
    Tao, Yong
    Yuan, Danping
    Pang, Hongshuang
    Wu, Hongbiao
    Liu, Dongfang
    Jin, Ningning
    Wu, Ningning
    Qiu, Jianming
    Cao, Yuepeng
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2817 - 2829
  • [10] Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy
    Klepin, Heidi D.
    Sun, Can-Lan
    Smith, David D.
    Elias, Rawad
    Trevino, Kelly M.
    Bryant, Ashley Leak
    Li, Daneng
    Nelson, Christian
    Tew, William P.
    Mohile, Supriya G.
    Gajra, Ajeet
    Owusu, Cynthia
    Gross, Cary
    Lichtman, Stuart M.
    Katheria, Vani V.
    Muss, Hyman B.
    Chapman, Andrew E.
    Cohen, Harvey Jay
    Hurria, Arti
    Dale, William
    [J]. JCO ONCOLOGY PRACTICE, 2021, 17 (06) : E740 - E752
12345